IMMUNEO THERAPEUTICS

EUIPO EUIPO 2023 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark IMMUNEO THERAPEUTICS was filed as Figurative mark on 10/31/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/26/2024. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#Triangles or lines forming an angle with lines #Green #Black #Orange

Trademark Details Last update: April 10, 2024

Trademark form Figurative mark
File reference 018944438
Application date October 31, 2023
Publication date December 18, 2023
Entry date March 26, 2024
Expiration date October 31, 2033

Trademark owner

Lorenzstraße 29
76135 Karlsruhe
DE

Trademark representatives

Lise-Meitner-Straße 4 60486 Frankfurt am Main DE

goods and services

5 Medicine; Implantable medicines; Pharmaceutical drugs; Anti-cancer drugs; Medicines for human purposes; Synthetic peptides for pharmaceutical purposes; Anti-cancer preparations; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Anti-cancer preparations from hormones and antagonists; Medicinal preparations and substances; Pharmaceutical preparations and substances; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations and substances for use in oncology
10 Implantable drug delivery devices, in particular for subcutaneous drug delivery
41 Arranging and conducting of seminars in the field of oncology; arranging and conducting of medical training courses; Training services in the field of medical disorders and their treatment
42 Pharmaceutical drug development services; Scientific research for medical purposes in the area of cancerous diseases; Biological analysis; Biochemical analysis; Software design and development
44 Advisory services relating to pharmaceuticals; Medical analysis for cancer diagnosis, prognosis and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; Medical analysis services for the diagnosis of cancer; Medical services in the field of oncology; Medical consultations; Medical counseling; Consultancy and information services relating to medical products

Trademark history

Date Document number Area Entry
April 9, 2024 Change Representative, Published

ID: 11018944438